The successful treatment of tuberculosis (TB) requires long-term multidrug chemotherapy. Clinical trials to evaluate new drugs and regimens for TB treatment are protracted due to the slow clearance of Mycobacterium tuberculosis (Mtb) infection and the lack of early biomarkers to predict…
A metabolic biosignature of early response to anti-tuberculosis treatment
Friday, January 31, 2014
A metabolic biosignature of early response to anti-tuberculosis treatment
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment